{"version":"1.0","provider_name":"Kapitalis","provider_url":"https:\/\/kapitalis.com\/tunisie","title":"Tunisie : M\u00e9diS lance Glargine, un biosimilaire de l\u2019insuline - Kapitalis","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"wdTD06Fcwx\"><a href=\"https:\/\/kapitalis.com\/tunisie\/2022\/03\/18\/tunisie-medis-lance-glargine-un-biosimilaire-de-linsuline\/\">Tunisie : M\u00e9diS lance Glargine, un biosimilaire de l\u2019insuline<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/kapitalis.com\/tunisie\/2022\/03\/18\/tunisie-medis-lance-glargine-un-biosimilaire-de-linsuline\/embed\/#?secret=wdTD06Fcwx\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0Tunisie : M\u00e9diS lance Glargine, un biosimilaire de l\u2019insuline\u00a0\u00bb &#8212; Kapitalis\" data-secret=\"wdTD06Fcwx\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/kapitalis.com\/tunisie\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/kapitalis.com\/tunisie\/wp-content\/uploads\/2022\/05\/kapitalis-logo-fb.png","thumbnail_width":1200,"thumbnail_height":630,"description":"M\u00e9diS, acteur majeur de l\u2019industrie pharmaceutique en Tunisie, annonce le lancement du premier biosimilaire de l\u2019insuline Glargine destin\u00e9 au traitement du diab\u00e8te et sa mise sur le march\u00e9 le 18 f\u00e9vrier 2022 apr\u00e8s la parution de la circulaire du minist\u00e8re de la Sant\u00e9."}